TrialThe Lancet. Infectious diseases2019

Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial.

Mary K Muhindo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.